Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,71
0,00%
NASDAQ Composite
15.618,54
-0,25%
Bitcoin
58.044,03
-4,25%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oncorus Inc (ONCR) Oncorus Inc (ONCR) Notizie

ONCR

Oncorus (ONCR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCR
DataOraFonteTitoloSimboloCompagnia
07/08/202312:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONCROncorus Inc
03/08/202323:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ONCROncorus Inc
03/08/202322:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCROncorus Inc
26/06/202322:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCROncorus Inc
23/06/202312:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCROncorus Inc
16/06/202315:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCROncorus Inc
12/06/202312:45Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCROncorus Inc
01/06/202322:05GlobeNewswire Inc.Oncorus Announces Workforce Reduction PlanNASDAQ:ONCROncorus Inc
22/05/202322:05GlobeNewswire Inc.Oncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
16/05/202322:38Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ONCROncorus Inc
01/05/202313:36Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONCROncorus Inc
24/03/202321:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCROncorus Inc
24/03/202312:00GlobeNewswire Inc.Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
14/02/202314:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONCROncorus Inc
04/01/202313:00GlobeNewswire Inc.Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug CandidatesNASDAQ:ONCROncorus Inc
28/12/202200:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCROncorus Inc
22/12/202212:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ONCROncorus Inc
30/11/202213:00GlobeNewswire Inc.Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with CancerNASDAQ:ONCROncorus Inc
23/11/202214:00GlobeNewswire Inc.Oncorus to Participate in Upcoming Investor ConferencesNASDAQ:ONCROncorus Inc
18/11/202214:00GlobeNewswire Inc.Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual MeetingNASDAQ:ONCROncorus Inc
07/11/202212:15TipRanksOncorus (ONCR) Gets a Buy from H.C. WainwrightNASDAQ:ONCROncorus Inc
02/11/202221:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCROncorus Inc
02/11/202212:00GlobeNewswire Inc.Oncorus Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
01/11/202221:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCROncorus Inc
07/10/202215:00GlobeNewswire Inc.Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of CancerNASDAQ:ONCROncorus Inc
26/09/202213:00GlobeNewswire Inc.Oncorus to Present at Chardan’s 6th Annual Genetic Medicines ConferenceNASDAQ:ONCROncorus Inc
06/09/202213:00GlobeNewswire Inc.Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ONCROncorus Inc
15/08/202212:15TipRanksH.C. Wainwright Sticks to Its Buy Rating for Oncorus (ONCR)NASDAQ:ONCROncorus Inc
04/08/202213:00GlobeNewswire Inc.Oncorus Reports Second Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:ONCROncorus Inc
23/06/202213:00GlobeNewswire Inc.Oncorus Appoints Douglas Fambrough to Board of DirectorsNASDAQ:ONCROncorus Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ONCR

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network